Ola Elrouby

Pharco Corporate

SCHOLARLY PAPERS

1

DOWNLOADS

221

SSRN CITATIONS

0

CROSSREF CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Efficacy and Safety of Sofosbuvir/Daclatasvir in the Treatment of COVID-19: A Randomized, Controlled Study

Number of pages: 20 Posted: 06 Oct 2020
Mostafa Yakoot, Mostafa Yakoot, Basem Eysa, Essam Gouda, Andrew Hill, Sherine A. Helmy, Mahmoud R. Elsayed, Ambar Qavi, Kaitlyn McCann, Ola Elrouby, Amal Mohamed, Ehab Reyad, Mohamed M. Fawzi, Safaa Elmandouh, Wessam Abdellatif, Ahmed A. Zidan, Abd-Elmoniem Adel and Mohamad Hassany
Green Clinic and Research CenterGreen Clinic and Research Center, National Hepatology and Tropical Medicine Research Institute (NHTMRI), Alexandria University - Chest Diseases Department, University of Liverpool - Department of Translational Medicine, Pharco Corporate, Alexandria University - Chest Diseases Department, Imperial College London - School of Public Health, Imperial College London - School of Public Health, Pharco Corporate, National Hepatology and Tropical Medicine Research Institute (NHTMRI), National Hepatology and Tropical Medicine Research Institute (NHTMRI), National Hepatology and Tropical Medicine Research Institute (NHTMRI), National Hepatology and Tropical Medicine Research Institute (NHTMRI), National Hepatology and Tropical Medicine Research Institute (NHTMRI), National Hepatology and Tropical Medicine Research Institute (NHTMRI), National Hepatology and Tropical Medicine Research Institute (NHTMRI) and The Egyptian Ministry of Health and Population
Downloads 221 (266,355)
Citation 3

Abstract:

Loading...

COVID-19, Drug therapy, Sofosbuvir, Daclatasvir, Randomized controlled study